Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Novo's Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro
-
H.I.G. Capital Completes Acquisition of Torque
-
CarMax Announces Leadership Appointments to Further Unify End-to-End Customer Experience, Advance Strategy for Growth
-
Eliza Appoints Patrick Buell as Chief Deployment Officer
-
Radware Introduces Agent Trust Management to Help Businesses Securely Embrace the AI Agent Economy
-
Pappas urges property owners to pay Second Installment tax bills before Thursday, October 1 due date
-
Atomic Raises $12.5M to Build the AI Control System for Physical Goods Companies
-
WisdomTree Introduces WisdomTree Onchain™ as Tokenized Fund Assets Surpass $1.2 Billion
-
Voltropy unveils AI that can process 10x more data than top labs
-
Verdiva Bio Presents Preclinical Data on VRB-103, a Selective Oral Amylin Peptide Analog, at 62nd EASD Annual Meeting
-
Mojio Enters New Era as Force Fleet with 750 Million Miles of Traction and an AI Fleet Manager Built for SMBs
-
The Newly Reimagined & Renovated Embassy Suites by Hilton Orlando International Drive ICON Park Sets a New Standard for Small and Midsized Group Events
-
ModernFi Surpasses 1,000 Financial Institutions, Reinforcing Its Role as Critical Infrastructure for the U.S. Banking System
-
Whole AI Launches Fellowship Initiative; Dennis Moreau Named Whole AI Distinguished Trust & Information Architecture Fellow
-
Landscape Architecture Firm Hoerr Schaudt's Latest World-Class Destination Design, The Adventure Playscape, Has Record Opening Summer
-
Hope Isn’t an AI Strategy: RSA Agent ID Closes the Agentic Identity Gap for Highly Regulated Industries
-
Massachusetts Deepens Commitment to Road Safety with Mobile Wrong-Way Detection Trailers
-
Oura Postpones Initial Public Offering
-
O2 Launches Ironcore Paving and Appoints Jared O’Connell as CEO
-
Best AI Vector Generator (2026): CorelDRAW Recognized for New Text-to-Vector Tools by Software Experts
-
Wood Mackenzie: Europe's Power Sector Hits 80% Zero-Carbon Generation by 2030, But Misses Its Own Renewables Target
-
env zero Launches EZ Control, the Autonomous Cloud Control Plane for the AI Era
-
ThredUp Expands Into Live Shopping with Whatnot
-
Westlake to Optimize European Chlorovinyls Footprint with Closure of Cologne PVC Plant
-
ISG Welcomes Former Liberty Mutual COO James MacPhee to Board of Advisors
-
KBR Ammonia Technology Selected for One of the Largest Fertilizer Complexes in Saudi Arabia
-
Nespresso and Swarovski Invite You to Make Every Coffee Moment Shine
-
Blue Lagoon Starts Drilling at Dome Mountain Gold Mine
-
Aalberts reports the progress of its share buyback programme 21 September – 25 September 2026
-
Wood Mackenzie: Europe's Power Sector Hits 80% Zero-Carbon Generation by 2030, But Misses Its Own Renewables Target
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
iHuman Inc. Announces Second Quarter 2026 Unaudited Financial Results
-
20 Years Reveal a Changing Luxury Market as West Vancouver Prices Double
-
CarMax Reports Second Quarter Fiscal 2027 Results
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SENIOR PLC - Ordinary Shares
-
Hangzhou Investment Promotion Bureau: Hangzhou Finds a "Gateway to the Sea" in Hong Kong
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Residential Properties REIT plc - Ordinary Shares
-
Form 8.5 (EPT/RI)-Tribal Group Plc
-
Sage unveils the Financial Symphony – a musical composition that reveals the hidden rhythms of business
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-SThree Plc
-
Man Group PLC : Form 8.3 - Spire Healthcare Group Plc
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Uranium Energy Corp Reports Fiscal 2026 Results
-
oToBrite Teams Up with SINTRONES at APTA EXPO 2026 to Deliver a Comprehensive Bus Safety Solution
-
Form 8.3 - Sthree
-
Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation
-
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
-
Morpheus8 Three-Session Series Takes Two Months, Cami Aesthetics Notes
